Status:
UNKNOWN
Mobile Phone Daily Alarm To Improve Compliance Of Intranasal Corticosteroid Among Allergic Rhinitis Patients.
Lead Sponsor:
National University of Malaysia
Collaborating Sponsors:
Glenmark Pharmaceuticals S.A.
Conditions:
Rhinitis, Allergic
Compliance, Medication
Eligibility:
All Genders
15-66 years
Phase:
NA
Brief Summary
This is a randomized controlled trial to compare the compliance of allergic rhinitis patients towards intranasal steroids between those who use mobile daily alarm reminder and those who do not.
Detailed Description
In this single blinded RCT, adults with allergic rhinitis are randomized into either he intervention or control arm. The intervention involves installing an alarm with a prerecorded nmessage "Have you...
Eligibility Criteria
Inclusion
- • Patients aged 15 years old to 60 years old with persistent AR
- Positive SPT towards DF, DP, BT, cockroach, Aspergillus, Cat fur
- Own and able to operate functioning mobile smartphone with built in alarm
- Able to understand simple instructions
- Patients who can read in English and Malay
- Newly diagnosed AR or previous patients who only take intranasal corticosteroid less than 4 times per week
Exclusion
- • Patients on immunotherapy
- Patients with mild intermittent AR
- Pregnant patients
- Patient with psychiatric illness
- Patients with gross anatomical obstruction (severe DNS, gross polyposis, nasal tumour)
- Chronic rhinosinusitis(CRS) with or without nasal polyposis
- Patients who have adverse reaction towards INCS
- Patients with severe hearing loss
Key Trial Info
Start Date :
January 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2022
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT05286944
Start Date
January 19 2020
End Date
June 22 2022
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universiti Kebangsaan Malaysia Medical center
Kuala Lumpur, WP Kuala Lumpur, Malaysia, 56000